Ferrari, R.

patient perindopril study effect treatment disease europa trial artery disease heart event inhibitor diabetes reduction artery ace inhibitors blood placebo group population result baseline pressure heart failure analysis ace inhibition glucose function hypertension infarction inhibition therapy end point blood pressure enzyme mortality level table point treatment effect europa study outcome polymorphism prevention treatment bene fit failure signi syndrome investigator difference history europa trial revascularization angiotensin association value diabetes mellitus risk reduction receptor european factor response progress bene fit cardiology benefit death ace-inhibitor bradykinin peace glucose regulation cardiovasc dysfunction randomized endpoint nonfatal mi cad patients pharmacogenetic ficant month